Milestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note published on Friday morning. The brokerage issued a hold rating on the stock.

Milestone Scientific Price Performance

NYSE:MLSS opened at $1.10 on Friday. Milestone Scientific has a 1-year low of $0.52 and a 1-year high of $1.10. The firm has a 50 day simple moving average of $0.89 and a 200-day simple moving average of $0.75. The firm has a market cap of $84.95 million, a PE ratio of -11.00 and a beta of 0.88.

Milestone Scientific (NYSE:MLSS) last released its quarterly earnings data on Thursday, August 15th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.01). Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%. The business had revenue of $1.85 million during the quarter.

Insider Buying and Selling

In other Milestone Scientific news, Director Leonard Osser sold 141,913 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $0.95, for a total transaction of $134,817.35. Following the transaction, the director now owns 4,602,506 shares of the company’s stock, valued at approximately $4,372,380.70. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 24.75% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.